Large-scale testing (Phase 3)Looking for participantsNCT06744504
What this trial is testing
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
Who this might be right for
AMLRUNX1-RUNX1T1 Fusion Protein Expression
Institute of Hematology & Blood Diseases Hospital, China 284